Education
About Us
Working with TipRanks
Follow Us
Innovation1 Biotech (IVBT)
:IVBT
IVBT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.02
Previous CloseN/A
Volume1.00
Average Volume (3M)0.00
Market Cap
$4.49K
Enterprise ValueN/A
Total Cash (Recent Filing)$3.86K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.68
Shares Outstanding22,470,240
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Innovation1 Biotech News
PremiumCompany Announcements
Innovation1 Biotech Appoints New Chief Financial Officer---
IVBT FAQ
What was Innovation1 Biotech’s price range in the past 12 months?
Innovation1 Biotech lowest stock price was $0.02 and its highest was $0.02 in the past 12 months.
What is Innovation1 Biotech’s market cap?
Innovation1 Biotech’s market cap is $4.49K.
When is Innovation1 Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innovation1 Biotech’s earnings last quarter?
Currently, no data Available
Is Innovation1 Biotech overvalued?
According to Wall Street analysts Innovation1 Biotech’s price is currently Overvalued.
Does Innovation1 Biotech pay dividends?
Innovation1 Biotech does not currently pay dividends.
What is Innovation1 Biotech’s EPS estimate?
Innovation1 Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovation1 Biotech have?
Innovation1 Biotech has 22,470,240 shares outstanding.
What happened to Innovation1 Biotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Innovation1 Biotech?
Currently, no hedge funds are holding shares in IVBT
---
Company Description
Innovation1 Biotech
Innovation1 Biotech Inc., a drug discovery company, focuses on the development of modified schedule 1 molecules of botanical origin in the United States. Its portfolio includes five proprietary fully synthetic preclinical prodrugs addressing independent clinical indications comprising a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression; a novel cannabinoid and tree bark derived psychedelic for treatment of addiction; and three additional cannabinoid prodrugs addressing clinical indications of refractory pediatric epilepsy, hypertrophic scarring, and ocular inflammation. The company was formerly known as Gridiron BioNutrients, Inc. and changed its name to Innovation1 Biotech Inc. in March 2022. Innovation1 Biotech Inc. was founded in 2014 and is headquartered in New York, New York.
---
Technical Analysis
Cyclacel Pharmaceuticals
―
Plus Therapeutics
―
AIM ImmunoTech
―
VistaGen Therapeutics
―
Bioxcel Therapeutics
―
---